Sponsor:
ECOG-ACRIN Cancer Research Group
Code:
NCT03937635
Conditions
Smoldering Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Dexamethasone
Lenalidomide
Quality-of-Life Assessment
Questionnaire Administration
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2024-08-09.